Graves’ Disease – Argenx ARGX-113-25-GRD-3002

Graves’ Disease & Hyperthyroidism Study

Profound Research is enrolling a Graves’ Disease (GD) study that is assessing an investigational medication to see if it improves symptoms of GD and hyperthyroidism.

To be eligible to participate, you must: 

• Be at least 18 years of age 

• Have a Graves’ Disease diagnosis 

• Have active hyperthyroidism caused by Graves’ Disease 

• Have been treated with Methimazole (MMI) or Carbimazole (CBZ) for at least 3 months 

Additional criteria apply. 

Qualified participants will receive: 

• Study-related care and study medication at no cost 

• Financial compensation for time and travel expenses 

Call us at 248-282-3640 or complete the form and our team will reach out soon to help determine your eligibility.